Sign inJoin waitlistJoin the waitlist

Vivek Narayan

Chair · University of Pennsylvania Health System

Credentials: · · · ·

History

University of Pennsylvania Health System
Present
University of Pennsylvania Health System
Present
Perelman School of Medicine at the University of Pennsylvania
Present

University of Pennsylvania Health System
2014–2016
University of Pennsylvania Health System
2011–2014
University of Virginia School of Medicine
2006–2010

Research

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease
New England Journal of Medicine · 2021 · 594 citations
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Nature Medicine · 2022 · First of 41 authors · 466 citations
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury
Journal of Clinical Investigation · 2010 · 410 citations

Bonnie Ky
24 papers
David Vaughn
12 papers
ST
Samuel Takvorian
10 papers · 1 as a fellow
Susan Domchek
10 papers
Amy Clark
9 papers
BD
Biniyam Demissei
9 papers
Payal Shah
9 papers
Neha Vapiwala
8 papers
Ravi Parikh
8 papers · 4 as a fellow
Naomi Haas
7 papers
Rana McKay
7 papers · 2 as a resident
Ronac Mamtani
7 papers

Grants

Early Phase Clinical Trials of 211At-Meta-Astatobenzylguanidine for Children with Neuroblastoma and Adults with Advanced Neuroendocrine Cancers
National Cancer Institute · R01
Contact PI · $1.4M · University of Pennsylvania
2025–2030

Clinical trials

211At-MABG in Adults With Advanced Neuroendocrine Cancers
Principal investigator · Not yet recruiting · Phase 1
University of Pennsylvania
2026–2032
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study
Principal investigator · Recruiting
Vivek Narayan
2023–2026
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Principal investigator · Recruiting · Early phase 1
Abramson Cancer Center at Penn Medicine
2023–2028
A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Principal investigator · Completed · Phase 2
Abramson Cancer Center at Penn Medicine
2020–2024